Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
50242-0105-01 - POLATUZUMAB VEDOTIN 140 MG REC (OTHER 5006829) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 2, 2026 , from http://ppman.hank.ai/transparency/procedure/5006829/by-state?code_type=OTHER
“50242-0105-01 - POLATUZUMAB VEDOTIN 140 MG REC (OTHER 5006829) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/5006829/by-state?code_type=OTHER. Accessed
July 2, 2026 .
“50242-0105-01 - POLATUZUMAB VEDOTIN 140 MG REC (OTHER 5006829) by State,” HANK Price Transparency ,
accessed July 2, 2026 ,
http://ppman.hank.ai/transparency/procedure/5006829/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
5006829 — 50242-0105-01 - Polatuzumab Vedotin 140 Mg Rec
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$33,662
National median
$29,433 – $37,434
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 5006829 (OTHER), with interquartile range
State Median p25 p75
CO $33,662 $29,433 $37,434